Indies Pharma Jamaica Statistics

Total Valuation

Indies Pharma Jamaica has a market cap or net worth of JMD 4.14 billion. The enterprise value is 4.82 billion.

Market Cap	4.14B
Enterprise Value	4.82B

Important Dates

The last earnings date was Tuesday, September 17, 2024.

Earnings Date	Sep 17, 2024
Ex-Dividend Date	Jul 15, 2024

Share Statistics

Indies Pharma Jamaica has 1.33 billion shares outstanding. The number of shares has increased by 1.57% in one year.

Shares Outstanding	1.33B
Shares Change (YoY)	+1.57%
Shares Change (QoQ)	+18.38%
Owned by Insiders (%)	5.77%
Owned by Institutions (%)	9.04%
Float	247.71M

Valuation Ratios

The trailing PE ratio is 19.43.

PE Ratio	19.43
Forward PE	n/a
PS Ratio	3.69
PB Ratio	3.32
P/FCF Ratio	22.45
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.06, with an EV/FCF ratio of 26.13.

EV / Earnings	22.38
EV / Sales	4.25
EV / EBITDA	15.06
EV / EBIT	16.58
EV / FCF	26.13

Financial Position

The company has a current ratio of 8.40, with a Debt / Equity ratio of 0.69.

Current Ratio	8.40
Quick Ratio	4.55
Debt / Equity	0.69
Debt / EBITDA	2.70
Debt / FCF	4.69
Interest Coverage	4.87

Financial Efficiency

Return on equity (ROE) is 17.74% and return on invested capital (ROIC) is 8.65%.

Return on Equity (ROE)	17.74%
Return on Assets (ROA)	8.28%
Return on Capital (ROIC)	8.65%
Revenue Per Employee	16.00M
Profits Per Employee	3.04M
Employee Count	71
Asset Turnover	0.52
Inventory Turnover	1.89

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +7.94% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+7.94%
50-Day Moving Average	2.75
200-Day Moving Average	2.72
Relative Strength Index (RSI)	55.23
Average Volume (20 Days)	1,264,154

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Indies Pharma Jamaica had revenue of JMD 1.14 billion and earned 215.57 million in profits. Earnings per share was 0.16.

Revenue	1.14B
Gross Profit	671.40M
Operating Income	290.84M
Pretax Income	245.10M
Net Income	215.57M
EBITDA	279.11M
EBIT	290.84M
Earnings Per Share (EPS)	0.16

Full Income Statement

Balance Sheet

The company has 185.77 million in cash and 865.19 million in debt, giving a net cash position of -679.41 million or -0.51 per share.

Cash & Cash Equivalents	185.77M
Total Debt	865.19M
Net Cash	-679.41M
Net Cash Per Share	-0.51
Equity (Book Value)	1.25B
Book Value Per Share	0.94
Working Capital	666.79M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 188.00 million and capital expenditures -3.40 million, giving a free cash flow of 184.61 million.

Operating Cash Flow	188.00M
Capital Expenditures	-3.40M
Free Cash Flow	184.61M
FCF Per Share	0.14

Full Cash Flow Statement

Margins

Gross margin is 59.11%, with operating and profit margins of 25.61% and 18.98%.

Gross Margin	59.11%
Operating Margin	25.61%
Pretax Margin	21.58%
Profit Margin	18.98%
EBITDA Margin	24.57%
EBIT Margin	25.61%
FCF Margin	16.25%

Dividends & Yields

This stock pays an annual dividend of 0.11, which amounts to a dividend yield of 3.20%.

Dividend Per Share	0.11
Dividend Yield	3.20%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	2
Payout Ratio	68.18%
Buyback Yield	-1.57%
Shareholder Yield	1.63%
Earnings Yield	5.15%
FCF Yield	4.45%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Indies Pharma Jamaica has an Altman Z-Score of 3.92.

Altman Z-Score	3.92
Piotroski F-Score	n/a